Simian virus 40 infection via MHC class I molecules and caveolae

Immunological Reviews

Volumn 168, Issue , 1999, Pages 13-22

  Norkin, Leonard C ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CHOLESTEROL; GLYCOSPHINGOLIPID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL SURFACE; EMBRYO; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOSOME; HOST CELL; LYSOSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; VIRUS INFECTION;

ANIMALS; CELL MEMBRANE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; PAPILLOMAVIRUS INFECTIONS; RECEPTORS, VIRUS; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS;

EID: 0033062572     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01279.x     Document Type: Article

References (55)

1. 1. Atwood WJ, Norkin LC. Class I major histocompatibility proteins as cell surface receptors for simian virus 40. J Virol 1989;63:4474-4477.
2. 2. Breau WC, Atwood WJ, Norkin LC. Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J Virol 1991;66:2037-2045.
3. 3. Marsh J, Helenius A. Virus entry into animal cells. Adv Virus Res 1989;36:107-151.
4. 4. Marsh M. Pelchen-Mathews A. The endocytic pathway and virus entry. In: Wimmer E. ed. Cellular receptors for animal viruses. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1994. p. 215-240.
5. 5. Mackay R, Consigli RA. Early events in polyoma virus infection: attachment, penetration, and nuclear entry. J Virol 1976;19:620-636.
6. 6. Basak S, Turner H. Infectious entry pathway for canine parvovirus. Virology 1991;186:368-376.
7. 7. Maul GG, Rovera G, Vorbradt A, Abrumczuk J. Membrane fusion as a mechanism of simian virus 40 entry into different cellular compartments. J Virol 1978:28:936-944.
8. 8. Kartenbeck J, Stukenbrok H, Helenius A. Endocytosis ot simian virus 40 into the endoplasmic reticulum. J Cell Biol 1989;189:2721-2729.
9. 9. Anderson HA, Chen Y, Norkin LC. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolac. Mol Biol Cell 1996;7:1825-1834.
10. 10. Slang E, Kartenbeck J, Parton RG. Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. Mol Biol Cell 1997;8:47-57.
11. 11. Dangoria NS, Breau WC, Anderson HA, Cishek DM, Norkin LC. Extracellular simian virus 40 induces an ERK/MAP kinase-indepcndent signalling pathway that activates primary response genes and promotes virus entry. J Gen Virol 1996;77:2173-2182.
12. 12. Chen Y, Norkin LC. Extracellular simian virus 40 transmits a signal that promotes virus enclosure within caveolae. Exp Cell Res 1999;246:83-90.
13. 13. Norkin LC, Anderson HA. Multiple stages of virus-receptor interactions as shown by simian virus 40. Adv Exp Med Biol 1996;408:159-167.
14. 14. Cole CN. Polyomaviridae: the viruses and their replication. In: Fields BN, Knipe DA, Howley PM, eds. Fundamental virology. Philadelphia: Lippincott-Raven; 1996. p. 917-946.
15. 15. Sweet BH, Hillman MR, The vacuolating virus. SV40. Proc Soc Exp Med Biol 1960;105:420-427.
16. 16. Barbanti-Brodano G, Martini F, De Mattei M, Lazzarin L, Corallini A, Tognon M. BK and JC human polyomaviruses and simian virus 40: natural history of infections in humans, experimental oncogenicity, and association with human tumors. Adv Virus Res 1998;50:69-99.
17. 17. Norkin L. Papovaviral persistent infections. Microbiol Rev 1982;46:384-425.
18. 18. Norkin LC, Steinberg VI, Kosz-Vnenchak M. Human glioblastoma cells persistently infected with simian virus 40 carry nondefective episomal viral DNA and acquire the transformed phenotype and numerous chromosomal abnormalities, J Virol 1985:53:658-666.
19. 19. Tevethia SS, Tevethia, MJ. Cytotoxic T-lymphocyte recognition of simian virus 40 antigens. Cancer Surv 1985;4:101-114.
20. 20. Brickell PM, Latchman DS, Murphy D, Willison K, Rigby PWJ. The class I major histocompatibility antigen gene activated in a line of SV40 transformed mouse cells is H-2D, not Qa/Tla. Nature 1985;316:162-163.
21. 21. Haddada H, et al. Viral gene inhibition of class I major histocompatibility antigen expression: not a general mechanism governing the tumorigenicity of adenovirus type 2-, adenovirus type 12-, and simian virus 40-transformed Syrian hamster cells. J Virol 1988;62:2755-2761.
22. 22. Eggleton KH, Norkin LC. Cell killing by simian virus 40: the sequence of ultrastructural alterations leading to cellular degeneration and death. Virology 1981;110:73-86.
23. 23. Clayson ET, Compans RW. Characterization of simian virus 40 receptor moieties on the surfaces of Vero C1008 cells. J Virol 1989;63:1095-1100.
24. 24. Sanjuan S, Zijlstra M, Carroll J, Jaenisch R, Benjamin T. Infection by polyomavirus of cells deficient in major histocompatibility complex expression. J Virol 1992;66:4587-4590.
25. 25. Liu CK, Wei G, Atwood WJ. The human polyomavirus, JCV, does not share receptor specificity with SV40 on human glial cells. J Neurovirol 1998;4:49-58.
26. 26. Hahn G, Keppler OT, Boch CT, Herrman M, Zentgraf H, Paulita M. The cell surface receptor is a major determinant restricting the host range of the B-lymphotropic papovavirus. J Virol 1993;67:7482-7492.
27. 27. Norkin LC. Virus receptors: implications for pathogenesis and the design of antiviral agents. Clin Microbiol Rev 1995;8:293-315.
28. 28. Norkin LC, Einck KH. Cell killing by simian virus 40: protective effect of chloroquine. Antimicrob Agents Chemother 1978;14:930-932.
29. 29. Anderson RGW. The caveolae membrane system. Annu Rev Biochem 1998;67:199-225.
30. 30. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569-572.
31. 31. Rothberg KG, Heuser JE, Donzell WC, Ying Y-S, Glenney JR, Anderson RGW. Caveolin, a protein component of caveolar coats. Cell 1992;68:673-682.
32. 32. Lisanti MP, Tang ZL, Sargiacomo M. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae. J Cell Biol 1993;123:595-604.
33. 33. Smart EJ, Foster DC, Ying Y, Kamen EA, Anderson RGW. Protein kinase activators inhibit receptor-mediated protocytosis by preventing internalization of caveolae. J Cell Biol 1994;124:307-313.
34. 34. Yewdell JW, Bennink JR. Cell biology of antigen processing and presentation to MHC class I restricted T lymphocytes. Adv Immunol 1992;52:1-24.
35. 35. Anderson HA, Chen Y, Norkin LC. MHC class I molecules are enriched in caveolae but do not enter with simian virus 40. J Gen Virol 1998:79:1469-1477.
36. 36. Clever J, Yamada M, Kasamatsu H. Import of simian virus 40 virions through nuclear pore complexes. Proc Natl Acad Sci USA 1991;88:7333-7337.
37. 37. Simionescu M, Sirnionescu N, Palade GE. Differential microdomains on the luminal surface of capillary endothelium: distribution of leptin receptors. J Cell Biol 1982;94:406-413.
38. 38. Schnitzer JE, Oh P, Pinney E, Allard J. Filipen-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 1994;127:1217-1232.
39. 5 promote adenovirus internalization but not virus attachment. Cell 1993;73:309-314.
40. 40. McClain D, Fuller AO. Cell-specific kinetics and efficiency of herpes simplex type I entry are determined by two distinct phases of attachment. Virology 1994;19:690-702.
41. 41. Deng H, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996:281:661-666.
42. + cells is mediated by the chemokine receptor CC-CKR-S. Nature 1996;281:667-673.
43. 43. Itoh N, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243.
44. 44. Anderson RGW. Caveolae: where incoming and outgoing signals meet. Proc Natl Acad Sci USA 1993;90:10909-10913.
45. 45. Lisanti MP, Scherer PE, Tang Z, Sargiacomo M. Caveolae, caveolin, and caveolin-rich membrane domains: a signaling hypothesis. Trends Cell Biol 1994;4:231-235.
46. 46. Schnitzer JE, McIntosh DP, Dvorak AM, Liu J, Oh P. Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 1995;269:1435-1439.
47. 2-microglobulin-free MHC class I molecules induced on activated T cells. Cell Immunol 1992;142:103-113.
48. 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J Biol Chem 1994;269:6689-6694.
49. 49. Ljunggren HG, et al. Empty class I molecules come out in the cold. Nature 1990;346:476-480.
50. 50. Neefjes J, Smit L, Gehrmann M, Ploegh HL. The fate of the three subunits of major histocompatibility complex class I molecules. Eur J Immunol 1992;2:1609-1614.
51. 51. Ortiz-Navarret V, Hammerling GJ. Surface appearance and instability of empty H-2 class I molecules under physiological conditions. Proc Natl Acad Sci USA 1991;88:3594-3597.
52. b class I major histocompatibility complex binding of exogenous peptides. Proc Natl Acad Sci USA 1990;87:7517-7521.
53. 53. Montesano R, Roth J, Robert A, Orci L. Non coated membrane invaginations are involved in binding and internalization of tetanus toxins. Nature 1982;296:651-653.
54. 54. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF. Induction of caveolin during adipogenesis and association of GLUT 4 with caveolin-rich vesicles. J Cell Biol 1994;127:1233-1243.
55. 55. Sargiacomo M, Sudel S, Tank ZL, Lisanti MP. Signal transducing molecules and glycosylphosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 1993;122:789-807.